Delivery Order SPE2DR25D1109-SPE2DR26FFK0L
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,728.74 to AmerisourceBergen Drug Corp for Naftifine HCL 2% Cream (45 grams) on December 11, 2025, with completion scheduled for December 12, 2025. This competitively awarded, firm fixed-price contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Naftifine HCL 1% Cream in 60-gram units, valued at $2,502.11. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract was executed with an ultimate completion date of September 4, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Naftifine HCL 1% Cream in 60-gram units, with a contract ceiling value of $2,978.42. This delivery order is issued under a firm fixed-price arrangement without any set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract has...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Naftifine HCL 2% Cream in 60-gram quantities, with a ceiling value of $8,129.88 and completion targeted for October 15, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Naftifine HCL 1% Cream in 60-gram quantities, valued at $3,125.15 with a completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,961.53 to AmerisourceBergen Drug Corp for Naftifine HCL 1% Cream in 60-gram units. This firm fixed-price contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside delivery order under DLA's pharmaceutical supply chain. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Naftifine HCL 1% Cream in 60-gram units, valued at $1,610.25 under a firm fixed-price contract with an ultimate completion date of December 17, 2025. This competitive award, made without set-aside designation, represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contractor will perform work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,182.95 of Naftifine HCL 1% Cream (60GM) with an ultimate completion date of October 29, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single-line item pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Naftifine HCL 2% Gel in 60-gram units, with a ceiling value of $2,343.43. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor. The contract is scheduled for completion by November 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Naftifine HCL 1% Cream 60GM on November 17, 2025, with a ceiling value of $2,603.88 and an ultimate completion date of November 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical procurement action under the company's existing contract vehicle...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFK0LDelivery Order
The Defense Logistics Agency awarded a $1,434.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Naftifine HCL 2% Cream in 60-gram units. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of January 6, 2026, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages this expansive IDC vehicle to supply a comprehensive range of pharmaceutical products and medical supplies to support military and federal healthcare systems globally. The prime indefinite delivery contract serves as a flexible procurement mechanism enabling the company to fulfill diverse medical supply needs across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard. This particular delivery order for topical antifungal medication reflects the company's role as a critical vendor within the federal medical supply chain, supporting the Department of Defense's pharmaceutical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/4/26 |